There are already 20 clinical trials underway through the collaboration, with additional studies expected to be introduced over time, Catholic Health said. Trials and treatments will be administered locally at most Catholic Health Cancer Institute locations, allowing patients to receive advanced care closer to home.
“This collaboration represents an important step forward in expanding access to advanced cancer care for patients and communities across Long Island,” Gary Havican, interim president and CEO and chief operating officer of Catholic Health, said. “By working with the HICCC at NewYork-Presbyterian/Columbia, we are able to bring innovative cancer therapies and select clinical trials closer to home, giving patients greater access to highly specialized, personalized treatment within their own communities.”